Form 4: Precision BioSciences CFO Acquires 3,000 Shares

Precision BioSciences' Chief Financial Officer, John Alexander Kelly, purchased 3,000 shares of the company's common stock at a price of $6.76 per share.

Summary

• John Alexander Kelly, the Chief Financial Officer of Precision BioSciences, Inc., acquired 3,000 shares of common stock on November 21, 2024.
• The shares were purchased at a price of $6.76 per share.
• Following this transaction, Mr. Kelly directly owns 38,073 shares of Precision BioSciences common stock.

Sentiment

Score: 6

Explanation: The document reflects a routine insider transaction, which is generally neutral to slightly positive. The CFO's purchase suggests confidence, but it's not a major event.

Positives

• The purchase of shares by a company executive can be seen as a positive sign of confidence in the company's future prospects.

Industry Context

Insider trading activity is closely monitored by investors as it can provide insights into management's view of the company's prospects. This purchase by the CFO could be interpreted as a positive signal.

Comparison to Industry Standards

• It is common for executives to purchase shares in their own companies, and the size of this purchase is not unusual for a CFO.
• Comparable companies often see similar insider trading activity, with the significance of the transaction depending on the size of the purchase relative to the executive's existing holdings and the company's overall market capitalization.

Stakeholder Impact

• The share purchase may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Precision BioSciences, John Alexander Kelly, insider trading, share purchase, common stock, CFO, DTIL